Teva Pharmaceutical Industries Ltd (TEVA)
18.76
+0.31
(+1.68%)
USD |
NYSE |
Nov 04, 13:16
Teva Pharmaceutical Industries 1 Year Total Returns (Daily): 110.6% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 110.6% |
October 31, 2024 | 114.9% |
October 30, 2024 | 117.4% |
October 29, 2024 | 127.0% |
October 28, 2024 | 126.2% |
October 25, 2024 | 118.0% |
October 24, 2024 | 122.8% |
October 23, 2024 | 125.1% |
October 22, 2024 | 126.4% |
October 21, 2024 | 123.9% |
October 18, 2024 | 112.2% |
October 17, 2024 | 107.4% |
October 16, 2024 | 106.2% |
October 15, 2024 | 109.6% |
October 14, 2024 | 99.08% |
October 11, 2024 | 90.82% |
October 10, 2024 | 88.22% |
October 09, 2024 | 101.0% |
October 08, 2024 | 86.09% |
October 07, 2024 | 83.44% |
October 04, 2024 | 90.32% |
October 03, 2024 | 81.04% |
October 02, 2024 | 74.43% |
October 01, 2024 | 73.24% |
September 30, 2024 | 76.67% |
Date | Value |
---|---|
September 27, 2024 | 74.43% |
September 26, 2024 | 73.58% |
September 25, 2024 | 70.34% |
September 24, 2024 | 71.30% |
September 23, 2024 | 71.21% |
September 20, 2024 | 63.64% |
September 19, 2024 | 72.59% |
September 18, 2024 | 69.64% |
September 17, 2024 | 68.56% |
September 16, 2024 | 70.63% |
September 13, 2024 | 78.22% |
September 12, 2024 | 79.56% |
September 11, 2024 | 78.88% |
September 10, 2024 | 82.12% |
September 09, 2024 | 85.03% |
September 06, 2024 | 90.72% |
September 05, 2024 | 92.78% |
September 04, 2024 | 92.68% |
September 03, 2024 | 88.21% |
August 30, 2024 | 94.74% |
August 29, 2024 | 92.10% |
August 28, 2024 | 91.93% |
August 27, 2024 | 93.40% |
August 26, 2024 | 91.75% |
August 23, 2024 | 90.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.92%
Minimum
Nov 06 2019
136.6%
Maximum
Jun 11 2024
9.84%
Average
1.45%
Median
1 Year Total Returns (Daily) Benchmarks
Amicus Therapeutics Inc | 4.46% |
Compugen Ltd | 125.0% |
Pluri Inc | 14.39% |
Can Fite Biofarma Ltd | 1.41% |
BiomX Inc | -76.12% |